About
Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular TherapyNJ, NY, PA
Team (2)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
120
By Phase
PHASE1: 2
By Status
RECRUITING: 2ENROLLING_BY_INVITATION: 1WITHDRAWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
Hover over trial bars to see details
Recent Trials
NCT06701201Lead Sponsor
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
N/AEnrolling by invitation
60 participants
Started: Jan 27, 2025 · Completed: Feb 28, 2042
NCT06544265Lead Sponsor
SynKIR-310 for Relapsed/Refractory B-NHL
PHASE1Recruiting
18 participants
Started: Nov 1, 2024 · Completed: Dec 31, 2028
NCT06377202Lead Sponsor
Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies
N/AWithdrawn
Started: Nov 15, 2023 · Completed: Dec 15, 2038
NCT05568680Lead Sponsor
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
PHASE1Recruiting
42 participants
Started: Mar 30, 2023 · Completed: Dec 31, 2027
Locations (1)
Headquarters
Philadelphia, PA, United States
Map
Loading map...